As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cancer Therapeutics Market: By Top Selling Drugs: Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Others; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Cancer Therapeutics Market Outlook

The global cancer therapeutics market stood at a value of USD 109,268.7 million in 2020 and is expected to achieve USD 194,634.5 million by 2026, recording a CAGR of 10.1% between 2021 and 2026.

 

The cancer therapeutics market is being driven by the increased investment by companies in the R&D sector. The increasing incidences of cancer across the globe are also adding to the cancer therapeutics market growth.

 

Global Cancer Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Cancer therapy includes the use and administration of chemotherapy and oncology drugs for the treatment of cancer. It is a type of treatment that identifies and attacks particular kinds of cancer cells with less damage to ordinary cells with the help of drugs or other substances. Some targeted therapies block certain enzymes, proteins, or other molecules that are engaged in cancer cell development.

 

Global Cancer Therapeutics Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The cancer therapeutics market can be divided on the basis of segments like application and top-selling drugs. The industry can be broadly categorised based on its application into:

  • Blood cancer
  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Cervical cancer
  • Head and neck cancer
  • Glioblastoma
  • Malignant Meningioma
  • Mesothelioma
  • Melanoma
  • Others

The cancer therapeutics market can be divided on the basis of its top-selling drugs as Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, and Temodar, among others.

The EMR report looks into the regional cancer therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Cancer Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

An increase in the incidences of cancer, rising cooperation among pharmaceutical companies, and growing innovation in the cancer-research sector are factors that are driving the growth of the cancer therapeutics industry. It is anticipated that the geriatric population will increase over the forecast period, further increasing the demand for cancer therapy. Further, the rising demand for personalised medicine and increased investment in the healthcare sector, particularly in developing countries, is providing the cancer therapeutics market with new growth opportunities. Some of the factors that restrict cancer therapeutics market growth are high costs connected with oncology drug development and adverse effects associated with cancer therapy.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global cancer therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc. (NYSE: ABBV)
  • Astellas Pharma Inc. 
  • Bristol Myers Squibb Company 
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd. 
  • Johnson & Johnson 
  • Merck & Co., Inc. 
  • Novartis AG 
  • Pfizer Inc. 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Questions Answered in the Report

  • How has the global cancer therapeutics market performed in the previous years (2016-2020)?
  • What is the forecasted assessment of the cancer therapeutics market for 2021-2026?
  • What are the major drivers for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major demand indicators of the global cancer therapeutics market?
  • What is the degree of competition in the global cancer therapeutics market?
  • What are the major events and developments taking place within the industry globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6     Global Cancer Therapeutics Market Analysis
    6.1     Global Cancer Therapeutics Historical Market (2016-2020) & Forecast (2021-2026)
    6.2     Global Cancer Therapeutics Market Breakup by Top Selling Drugs
        6.2.1    Revlimid
        6.2.2    Avastin
        6.2.3    Herceptin
        6.2.4    Rituxan
        6.2.5    Opdivo
        6.2.6    Gleevec
        6.2.7    Velcade
        6.2.8    Imbruvica
        6.2.9    Ibrance
        6.2.10    Zytiga
        6.2.11    Alimta
        6.2.12    Xtandi
        6.2.13    Tarceva
        6.2.14    Perjeta
        6.2.15    Temodar
        6.2.16    Others
    6.3     Global Cancer Therapeutics Market Breakup by Top Selling Drugs: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Revlimid
        6.3.2    Avastin
        6.3.3    Herceptin
        6.3.4    Rituxan
        6.3.5    Opdivo
        6.3.6    Gleevec
        6.3.7    Velcade
        6.3.8    Imbruvica
        6.3.9    Ibrance
        6.3.10    Zytiga
        6.3.11    Alimta
        6.3.12    Xtandi
        6.3.13    Tarceva
        6.3.14    Perjeta
        6.3.15    Temodar
        6.3.16    Others
    6.4     Global Cancer Therapeutics Market by Application
        6.4.1    Blood Cancer
        6.4.2    Lung Cancer
        6.4.3    Breast Cancer
        6.4.4    Colorectal Cancer
        6.4.5    Prostate Cancer
        6.4.6    Cervical Cancer
        6.4.7    Head & Neck Cancer
        6.4.8    Glioblastoma
        6.4.9    Malignant Meningioma
        6.4.10    Mesothelioma
        6.4.11    Melanoma
        6.4.12    Others
    6.5     Global Cancer Therapeutics Market by Application: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    Blood Cancer
        6.5.2    Lung Cancer
        6.5.3    Breast Cancer
        6.5.4    Colorectal Cancer
        6.5.5    Prostate Cancer
        6.5.6    Cervical Cancer
        6.5.7    Head & Neck Cancer
        6.5.8    Glioblastoma
        6.5.9    Malignant Meningioma
        6.5.10    Mesothelioma
        6.5.11    Melanoma
        6.5.12    Others
    6.6     Global Cancer Therapeutics Market Breakup by Region
        6.6.1    North America
            6.6.1.1    United States of America
            6.6.1.2    Canada
        6.6.2    Europe
            6.6.2.1    Germany
            6.6.2.2    United Kingdom
            6.6.2.3    France
            6.6.2.4    Italy
            6.6.2.5    Others
        6.6.3    Asia Pacific
            6.6.3.1    China
            6.6.3.2    Japan
            6.6.3.3    India
            6.6.3.4    ASEAN
            6.6.3.5    Others
        6.6.4    Latin America
            6.6.4.1    Brazil
            6.6.4.2    Argentina
            6.6.4.3    Mexico
            6.6.4.4    Others
        6.6.5    Middle East & Africa
            6.6.5.1    Saudi Arabia
            6.6.5.2    United Arab Emirates
            6.6.5.3    Nigeria
            6.6.5.4    South Africa
            6.6.5.5    Others
    6.7     Global Cancer Therapeutics Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.7.1    North America
            6.7.1.1    United States of America
            6.7.1.2    Canada
        6.7.2    Europe
            6.7.2.1    Germany
            6.7.2.2    United Kingdom
            6.7.2.3    France
            6.7.2.4    Italy
            6.7.2.5    Others
        6.7.3    Asia Pacific
            6.7.3.1    China
            6.7.3.2    Japan
            6.7.3.3    India
            6.7.3.4    ASEAN
            6.7.3.5    Others
        6.7.4    Latin America
            6.7.4.1    Brazil
            6.7.4.2    Argentina
            6.7.4.3    Mexico
            6.7.4.4    Others
        6.7.5    Middle East & Africa
            6.7.5.1    Saudi Arabia
            6.7.5.2    United Arab Emirates
            6.7.5.3    Nigeria
            6.7.5.4    South Africa
            6.7.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis 
    9.1    AbbVie Inc. [ABBV (NYSE)]
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Astellas Pharma Inc. [4503 (TYO)]
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Bristol Myers Squibb Company [BMY (NYSE)]
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Celgene Corporation [CELG (NASDAQ)]
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    F. Hoffmann-La Roche Ltd. [ROG (SWX)]
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Johnson & Johnson [JNJ (NYSE)]
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Merck & Co., Inc. [MRK (NYSE)]
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Novartis AG [NOVN (SWX)]
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Pfizer Inc. [PFE (NYSE)]
        9.9.1    Company Overview
        9.9.2    Financial Analysis
    9.10    Others
10    Industry Events and Developments

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Oxygen Therapy Market Report and Forecast 2021-2026


Global Topical Pain Relief Market Report and Forecast 2021-2026


Global Aortic Valve Replacement Market Report and Forecast 2021-2026


Global Radiation Oncology Market Report and Forecast 2021-2026


Global Noninvasive Neuromodulation Market Report and Forecast 2021-2026


NEWSLETTER